Velocity’s research site in Dallas was founded in 1990 as Dallas Diabetes Research Center and acquired by Velocity in 2022. With hundreds of endocrinology studies completed, the Dallas site is a leader in conducting diabetes, obesity, and NASH trials. The experienced Dallas staff maintains the highest quality and safety standard while continually meeting their goals for recruitment.
Located on campus of the local hospital, accessibility and patient parking are no issue for the Dallas site. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Dallas team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.